Hyun's Ceftriaxone Sodium Injection 500mg

Adult administration

In adults and children over 12 years old, administer 1-2g (potency) of ceftriaxone daily via intravenous or intramuscular injection. For infections caused by severe or moderately sensitive pathogens, the dose may be increased to 4g (potency) once a day. Elderly patients do not need to change the adult dosage. For the treatment of gonorrhea, a single intramuscular injection of 250mg (potency) is recommended. Prevention of surgical infections

Child administration

In neonates (within 14 days of birth), administer 20-50mg (potency) per kg of body weight once daily, not exceeding 50mg (potency). Infants and children (from 15 days to 12 years) should receive 20-

This medicine should not be mixed or administered simultaneously with solutions containing calcium. Particularly in newborns, there is a risk of precipitation when calcium meets this drug, so it should not be administered. You must check for allergic reactions before administering this drug, and those with hypersensitivity to penicillin or cephalosporin antibiotics should not use it. Patients with poor kidney function and those with a history of allergies should use this drug with caution. Elderly patients or those in poor general condition may develop vitamin K deficiency and should undergo regular testing. This medicine can cause adverse reactions primarily in the blood and gastrointestinal tract, and side effects such as rash, diarrhea, and liver function abnormalities have been reported. Rarely, severe allergic reactions, neurological issues, or skin adverse reactions may occur, so immediate medical attention should be sought if symptoms arise. During administration, it is important to regularly check liver and kidney function and perform blood tests to monitor for abnormalities. The safety of this drug during pregnancy has not been established, so pregnant women should use it cautiously after consulting their physician, and nursing mothers should also be careful. Be cautious when driving or operating machinery as there may be side effects such as dizziness. In the case of overdose, there are no specific antidotes, so treatment should be symptomatic, and if taking other medications, it is essential to inform the healthcare provider about all medications being taken. This drug should not be used in newborns with high bilirubin levels or preterm infants, and particularly, it should not be administered with calcium-containing solutions to newborns. Prepared solutions should be used as soon as possible, and if stored, they should be used within 6 hours at room temperature or within 24 hours if refrigerated.

Serious side effects

Urticaria, severe swelling (edema), cold sweats, pallor, severe allergic reactions, rash, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, shortness of breath or difficulty breathing, yellowing of the skin or eyes (jaundice), extreme fatigue throughout the body, liver abnormalities (jaundice), sudden and severe headaches, thunderclap headaches, seizures, loss of consciousness

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• elevated liver enzymes
• itching
• headache
• dizziness
• loose stools

This drug should be stored in a tightly sealed container to prevent air or moisture from entering and should be kept at a temperature between 1 to 30 degrees Celsius. Storing it this way ensures that the effectiveness of the drug is well maintained.

Appearance

A vial containing a white to pale yellow powder

Package unit

1 vial